Comparative Performance of Urine Lipoarabinomannan and Urine Xpert MTB/RIF Ultra for Diagnosing Tuberculosis in Adult Inpatients With HIV in East London, South Africa
Clinical Infectious Diseases · 2025
DOI: 10.1093/cid/ciaf080 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von David Stead und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Frere and Cecilia Makiwane Hospitals, East London, South Africa. Hauptthemen laut MEDLINE: Lipopolysaccharides, HIV Infections, Tuberculosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wellcome Trust, Collaborating Centres Programme, NIH HHS.
Abstract (Originalsprache)
Background
Urine lateral flow lipoarabinomannan (LF-LAM) is a point-of-care tuberculosis (TB) test for patients with human immunodeficiency virus (HIV). Xpert MTB/RIF Ultra (Ultra) has improved sensitivity on sputum compared with the previous generation of Xpert and may improve diagnostic yield for TB on urine-based testing.
Methods
We conducted a diagnostic accuracy study in East London, South Africa. Adults with HIV hospitalized with ≥1 W4SS (World Health Organization–recommended 4-symptom screen) or clinical concern for TB were enrolled; TB cultures were performed on blood, sputum, and urine. Unprocessed urine was tested with LF-LAM and Ultra on the pellet of 15 mL centrifuged urine. The primary outcome was sensitivity of urine Ultra compared with LF-LAM, with microbiological TB (positive TB culture or molecular test, excluding urine Ultra) as the reference. Secondary outcomes included specificity and diagnostic yield.
Results
Two hundred thirty-eight participants were enrolled with a median CD4 count of 76 cells/mm3. Microbiological TB was diagnosed in 62 (26%). Using microbiological TB as the reference, sensitivity of LF-LAM and urine Ultra was 45% (95% confidence interval, 32–58) and 70% (95% CI, 57–81; McNemar P = .0013); specificity was 93% (95% CI, 81–99) and 100% (95% CI, 92–100; McNemar P = .25). Diagnostic yields for microbiological TB were 34% for sputum Ultra, 45% for urine LF-LAM, 68 for urine Ultra, and 73% for urine LF-LAM and urine Ultra combined.
Conclusions
Combined urine-based testing (Ultra + LF-LAM) identified nearly three-quarters of medical inpatients with HIV with microbiological TB. Urine Ultra had significantly improved sensitivity compared with LF-LAM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Frere and Cecilia Makiwane Hospitals, East London, South Africa.
- Department of Medicine, Faculty of Health Sciences, Walter Sisulu University, Mthatha, South Africa.
- Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
- Institute for Infection and Immunity, St George's, University of London, London, United Kingdom.
- Department of Statistical Sciences, University of Cape Town, Cape Town, South Africa.
- Department Infectious Diseases, Queen Elizabeth University Hospital, Glasgow, United Kingdom.
ORCID-Profile: David Stead, Sean Wasserman, Ebrahim Steenkamp, Andy Parrish, David Barr, Graeme Meintjes
Förderung
- Wellcome Trust
- Collaborating Centres Programme
- NIH HHS
- NIAID NIH HHS
- FIC NIH HHS
- National Research Foundation
- South African Research Chairs Initiative of the Department of Science and Technology
- South African Medical Research Council
Zitieren
APA
Stead, D., Wasserman, S., Steenkamp, E., Parrish, A., Barr, D., & Meintjes, G. (2025). Comparative Performance of Urine Lipoarabinomannan and Urine Xpert MTB/RIF Ultra for Diagnosing Tuberculosis in Adult Inpatients With HIV in East London, South Africa. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf080
Vancouver
Stead D, Wasserman S, Steenkamp E, Parrish A, Barr D, Meintjes G. Comparative Performance of Urine Lipoarabinomannan and Urine Xpert MTB/RIF Ultra for Diagnosing Tuberculosis in Adult Inpatients With HIV in East London, South Africa. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf080
BibTeX
@article{Stead2025,
author = {Stead, David and Wasserman, Sean and Steenkamp, Ebrahim and Parrish, Andy and Barr, David and Meintjes, Graeme},
title = {Comparative Performance of Urine Lipoarabinomannan and Urine Xpert MTB/RIF Ultra for Diagnosing Tuberculosis in Adult Inpatients With HIV in East London, South Africa},
journal = {Clinical Infectious Diseases},
year = {2025},
doi = {10.1093/cid/ciaf080}
}
EUVIMED